What to Expect From Teladoc Health’s Q1 Earnings Results?
<p>Analysts at RBC Capital provided their outlook on <a href='https://financialmodelingprep.com/financial-summary/TDOC'>Teladoc Health, Inc. (NYSE:TDOC) </a>ahead of the upcoming Q1 earnings report, scheduled on April 27.</p>
<p>The company’s management has guided to revenue in the range of $565-571 million and EBITDA in the range of $51-55M million. The analysts reiterated their $570 million and $54 million estimates for revenue and EBITDA, respectively (vs. Street’s $570 million and $53 million).</p>
<p>The analysts remain positive on the company into Q1 earnings based on its analysis of BetterHelp's digital traffic data, which points to activity across those channels growing over 35% year-over-year during the quarter. That said, while an in-line or better Q1 result would be encouraging, given investor discussions/feedback from their recent European marketing trip and the company’s H2-weighted 2022 guidance, the analysts are not expecting any meaningful inflection in shares until later in the year.</p>

NYSE:TDOC